- Report
- September 2023
- 24 Pages
Indonesia
From €825EUR$916USD£732GBP
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 114 Pages
New Zealand
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 25 Pages
New Zealand
From €825EUR$916USD£732GBP
- Report
- October 2023
- 108 Pages
Peru
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 25 Pages
Peru
From €825EUR$916USD£732GBP
- Report
- September 2023
- 98 Pages
Indonesia
From €2200EUR$2,442USD£1,953GBP
From €825EUR$916USD£732GBP
From €825EUR$916USD£732GBP
The Panadol market is part of the larger Over the Counter (OTC) Drugs market. OTC drugs are medications that can be purchased without a prescription from a healthcare professional. Panadol is a brand of paracetamol, a common pain reliever and fever reducer. It is available in a variety of forms, including tablets, capsules, and syrups.
Panadol is widely available in pharmacies, supermarkets, and other retail outlets. It is often used to treat mild to moderate pain, such as headaches, muscle aches, and menstrual cramps. It is also used to reduce fever and relieve the symptoms of colds and flu.
The Panadol market is highly competitive, with many companies offering their own brands of paracetamol. Some of the major players in the market include GlaxoSmithKline, Johnson & Johnson, Bayer, and Novartis. Other companies include Sanofi, Pfizer, and Merck. Show Less Read more